These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1157 related items for PubMed ID: 17967302

  • 21. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA, Jaggernauth W, Rigual NR, Hicks WL, Popat SR, Sullivan M, Mashtare TL, Khan MK, Loree TR, Singh AK.
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [Abstract] [Full Text] [Related]

  • 22. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
    Milano MT, Vokes EE, Kao J, Jackson W, List MA, Stenson KM, Witt ME, Dekker A, MacCracken E, Garofalo MC, Chmura SJ, Weichselbaum RR, Haraf DJ.
    Int J Oncol; 2006 May; 28(5):1141-51. PubMed ID: 16596230
    [Abstract] [Full Text] [Related]

  • 23. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
    Jabbari S, Kim HM, Feng M, Lin A, Tsien C, Elshaikh M, Terrel JE, Murdoch-Kinch C, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):725-31. PubMed ID: 16199308
    [Abstract] [Full Text] [Related]

  • 24. Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies.
    Kramer NM, Horwitz EM, Cheng J, Ridge JA, Feigenberg SJ, Cohen RB, Nicolaou N, Sherman EJ, Babb JS, Damsker JA, Langer CJ.
    Head Neck; 2005 May 01; 27(5):406-14. PubMed ID: 15719391
    [Abstract] [Full Text] [Related]

  • 25. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
    Salama JK, Mell LK, Schomas DA, Miller RC, Devisetty K, Jani AB, Mundt AJ, Roeske JC, Liauw SL, Chmura SJ.
    J Clin Oncol; 2007 Oct 10; 25(29):4581-6. PubMed ID: 17925552
    [Abstract] [Full Text] [Related]

  • 26. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
    Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.
    Cancer Chemother Pharmacol; 2008 Dec 10; 63(1):9-17. PubMed ID: 18343925
    [Abstract] [Full Text] [Related]

  • 27. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
    Stadler P, Putnik K, Kreimeyer T, Sprague LD, Koelbl O, Schäfer C.
    BMC Cancer; 2006 Dec 07; 6():279. PubMed ID: 17150114
    [Abstract] [Full Text] [Related]

  • 28. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience.
    Rwigema JC, Heron DE, Ferris RL, Gibson M, Quinn A, Yang Y, Ozhasoglu C, Burton S.
    Am J Clin Oncol; 2010 Jun 07; 33(3):286-93. PubMed ID: 19875950
    [Abstract] [Full Text] [Related]

  • 29. Multi-institutional review of repeat irradiation of chest wall and breast for recurrent breast cancer.
    Wahl AO, Rademaker A, Kiel KD, Jones EL, Marks LB, Croog V, McCormick BM, Hirsch A, Karkar A, Motwani SB, Tereffe W, Yu TK, Sher D, Silverstein J, Kachnic LA, Kesslering C, Freedman GM, Small W.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):477-84. PubMed ID: 17869019
    [Abstract] [Full Text] [Related]

  • 30. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G, Huguenin PU, Davis JB, Kunz G, Lütolf UM, Glanzmann C.
    Radiat Oncol; 2006 Mar 31; 1():7. PubMed ID: 16722599
    [Abstract] [Full Text] [Related]

  • 31. A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma.
    Lee NY, de Arruda FF, Puri DR, Wolden SL, Narayana A, Mechalakos J, Venkatraman ES, Kraus D, Shaha A, Shah JP, Pfister DG, Zelefsky MJ.
    Int J Radiat Oncol Biol Phys; 2006 Nov 15; 66(4):966-74. PubMed ID: 17145527
    [Abstract] [Full Text] [Related]

  • 32. Continuous-course reirradiation with concurrent carboplatin and paclitaxel for locally recurrent, nonmetastatic squamous cell carcinoma of the head-and-neck.
    Kharofa J, Choong N, Wang D, Firat S, Schultz C, Sadasiwan C, Wong S.
    Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):690-5. PubMed ID: 22112556
    [Abstract] [Full Text] [Related]

  • 33. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
    Yao M, Hoffman HT, Chang K, Funk GF, Smith RB, Tan H, Clamon GH, Dornfeld K, Buatti JM.
    Int J Radiat Oncol Biol Phys; 2007 Jul 01; 68(3):707-13. PubMed ID: 17379453
    [Abstract] [Full Text] [Related]

  • 34. Feasibility study of moderately accelerated intensity-modulated radiotherapy plus concurrent weekly cisplatin after induction chemotherapy in locally advanced head-and neck cancer.
    Morganti AG, Mignogna S, Deodato F, Massaccesi M, Cilla S, Calista F, Serafini G, Digesú C, Macchia G, Picardi V, Caravatta L, Di Lullo L, Giglio G, Sallustio G, Piermattei A, Cellini N, Valentini V.
    Int J Radiat Oncol Biol Phys; 2011 Mar 15; 79(4):1073-80. PubMed ID: 20472342
    [Abstract] [Full Text] [Related]

  • 35. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers.
    Watkins JM, Shirai KS, Wahlquist AE, Stuart RK, Chaudhary UB, Garrett-Mayer E, Day TA, Gillespie MB, Sharma AK.
    Head Neck; 2009 Apr 15; 31(4):493-502. PubMed ID: 19156831
    [Abstract] [Full Text] [Related]

  • 36. Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.
    Hua YJ, Han F, Lu LX, Mai HQ, Guo X, Hong MH, Lu TX, Zhao C.
    Eur J Cancer; 2012 Dec 15; 48(18):3422-8. PubMed ID: 22835782
    [Abstract] [Full Text] [Related]

  • 37. Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.
    Adelstein DJ, Saxton JP, Rybicki LA, Esclamado RM, Wood BG, Strome M, Lavertu P, Lorenz RR, Carroll MA.
    J Clin Oncol; 2006 Mar 01; 24(7):1064-71. PubMed ID: 16505425
    [Abstract] [Full Text] [Related]

  • 38. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF, Tseng CJ, Tseng CC, Yu CY, Wu CT, Chen WC.
    Cancer J; 2008 Mar 01; 14(3):200-6. PubMed ID: 18536561
    [Abstract] [Full Text] [Related]

  • 39. Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.
    Tham IW, Lin S, Pan J, Han L, Lu JJ, Wee J.
    Am J Clin Oncol; 2010 Jun 01; 33(3):294-9. PubMed ID: 20395788
    [Abstract] [Full Text] [Related]

  • 40. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H, Tsukuda M, Watai K.
    Cancer Chemother Pharmacol; 2007 Aug 01; 60(3):399-406. PubMed ID: 17096160
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.